Today: 26 April 2026
Subscribe
Browse Category

NYSE:THG 16 January 2026

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 16.01.2026

Hanover Insurance Group closed at $169.96, about 15% below its estimated fair value of $200.13, with analysts projecting 4.3% annual revenue growth. Vitalhub shares ended at CA$8.45, down 17.5% over 90 days, despite a fair value estimate of CA$15.53. Sampo Oyj traded at €10.00, showing a 24.9% discount to its €13.32 intrinsic value based on the Excess Returns model.
16 January 2026
···

Stock Market Today

  • Is Merck Stock Still Undervalued After 40% Gain in 1 Year?
    April 26, 2026, 2:07 AM EDT. Merck (MRK) shares have surged 40.2% over the past year, recently closing at $111.90. Despite short-term declines, the stock shows a 5.1% gain year-to-date. A Discounted Cash Flow (DCF) model estimates Merck's intrinsic value at $214.74, suggesting the stock trades at a 47.9% discount and may be undervalued. Merck's Price-to-Earnings (P/E) ratio stands at 15.1, reflecting market views on its earnings relative to price. These valuation models indicate that Merck could still offer attractive long-term investment prospects despite recent price volatility. Investors should consider these fundamentals beyond short-term market moves.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 26.04.2026

26 April 2026
LIVEMarkets rolling coverageStarted: April 26, 2026, 12:00 AM EDTUpdated: April 26, 2026, 2:07 AM EDT Is Merck Stock Still Undervalued After 40% Gain in 1 Year? April 26, 2026, 2:07 AM EDT. Merck (MRK) shares have surged 40.2% over the past year, recently closing at $111.90. Despite short-term declines, the stock shows a 5.1% gain year-to-date. A Discounted Cash Flow (DCF) model estimates Merck's intrinsic value at $214.74, suggesting the stock trades at a 47.9% discount and may be undervalued. Merck's Price-to-Earnings (P/E) ratio stands at 15.1, reflecting market views on its earnings relative to price. These valuation models indicate
Lockheed Martin Gets Golden Dome Opening as Profit Worries Bite

Lockheed Martin Gets Golden Dome Opening as Profit Worries Bite

26 April 2026
Lockheed Martin was named among firms awarded up to $3.2 billion for President Trump’s Golden Dome space-based missile interceptor plan, Space Systems Command said. The company reported weaker first-quarter results, with $18 billion in sales and negative free cash flow. Space Force aims to show initial interceptor capability in 2028. Golden Dome’s total cost is projected at $185 billion.
Go toTop